Series: A
Earlier Investors: Edgewood Growth Fund, Coty, Plug and Play Center, and PepsiCo Accelerator
Date of Investment: December 2023
Investment Amount: $1,000,000
Summary: LifeNome is a precision health and wellness platform focused on women and family health offering personalized services in nutrition, dieting, supplements, fitness, preventive wellbeing, and beauty.
Product offering: LifeNome is a personalized genomics AI-powered health subscription platform with both B2B and B2C offerings through channel partners. The company’s platform offers the following three products:
- Xscan: Provides customers with insights into their unique genetics and predispositions, including nutrition and diet, allergy and sensitivity, beauty, and fitness reports.
- Xhealth: Enables companies to provide their customers with tailor-made health and well-being interventions in the nutrition and diet, fitness, and sleep and stress management space.
- Xchoice: Upgrades customers’ shopping experience by providing clear and insightful choices in the form of product and lifestyle recommendations, personalized formulations, and personalized products.
- Initiated FDA approval process to allow insurance reimbursements. Also, expected to enter key partnerships and contracts in early 2024.
- Working on maternal health initiative through LG
- Offers 1,500+ genotype-phenotype traits, 5000+ pharmacogenomics traits, 400+ predisposition assessments, integrates 28,000+ clinical studies, includes a dataset of 530,000+ genotype-phenotype users, achieves predictive accuracies up to 90% and provides customizable API endpoints in 12 languages to date.
- 3 patents (filed and granted) in trait disposition assessment, nutritional/maternal and skin space.
LifeNome is a precision health and wellness platform focused on women and family health offering personalized services in nutrition, dieting, supplements, fitness, preventive wellbeing, and beauty.
